XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Grant and collaboration revenues $ 221,299 $ 295,735
Operating expenses:    
Research and development 486,994 551,795
General and administrative 357,228 292,667
Total operating expenses 844,222 844,462
Loss from operations (622,923) (548,727)
Other income (expense):    
Interest income 1,318 386
Interest expense (208)
Total other income (expense) 1,110 386
Net loss $ (621,813) $ (548,341)
Basic and diluted:    
Net loss per common share (in dollars per share) $ (0.01) $ (0.01)
Weighted average shares outstanding (in shares) 124,170,143 55,350,974